Treatment of Telangiectasia Macularis Eruptiva Perstans with an Intense Pulsed Light Device

Telangiectasia macularis eruptiva perstans (TMEP) is a rare adult mastocytosis with prominent cutaneous manifestations including red to brown telangiectatic macules typically on the chest or limbs. TMEP can be a cause of morbidity with associated cutaneous findings (e.g. flushing, pruritus, ulcers) and extracutaneous symptoms (e.g. dyspnea, reflux, diarrhea, hypotension). Previous attempts to treat the cutaneous manifestations of TMEP include PUVA, topical steroids, electron beam radiation, and 585-nm flashlamp-pumped dye laser. We report the first case of successful treatment of the cutaneous findings of TMEP with intense pulsed light (IPL). The patient underwent 2 treatments with IPL spaced 3 months apart, and remained entirely clear at 14 months follow-up.

Download Full-text

Application of Novel Non-Thermal Physical Technologies to Degrade Mycotoxins

Journal of Fungi ◽

10.3390/jof7050395 ◽

2021 ◽

Vol 7 (5) ◽

pp. 395

Author(s):

Mohammad Yousefi ◽

Masoud Aman Mohammadi ◽

Maryam Zabihzadeh Khajavi ◽

Ali Ehsani ◽

Vladimír Scholtz

Keyword(s):

Electron Beam ◽

Food Systems ◽

Large Scale ◽

Plasma Electron ◽

Pulsed Light ◽

Beam Radiation ◽

Practical Applications ◽

Electron Beam Radiation ◽

Non Thermal Plasma ◽

Agriculture And Food

Mycotoxins cause adverse effects on human health. Therefore, it is of the utmost importance to confront them, particularly in agriculture and food systems. Non-thermal plasma, electron beam radiation, and pulsed light are possible novel non-thermal technologies offering promising results in degrading mycotoxins with potential for practical applications. In this paper, the available publications are reviewed—some of them report efficiency of more than 90%, sometimes almost 100%. The mechanisms of action, advantages, efficacy, limitations, and undesirable effects are reviewed and discussed. The first foretastes of plasma and electron beam application in the industry are in the developing stages, while pulsed light has not been employed in large-scale application yet.

Download Full-text

Successful treatment of tufted angioma with low-dose electron beam radiation therapy: Report of two cases

The Journal of Dermatology ◽

10.1111/1346-8138.13936 ◽

2017 ◽

Vol 44 (10) ◽

pp. e262-e263 ◽

Cited By ~ 1

Author(s):

Ryoko Kimura ◽

Yuichi Yoshida ◽

Keiko Wakumoto ◽

Nanako Yamada ◽

Osamu Yamamoto

Keyword(s):

Radiation Therapy ◽

Electron Beam ◽

Successful Treatment ◽

Low Dose ◽

Beam Radiation ◽

Electron Beam Radiation ◽

Tufted Angioma

Download Full-text

Cutaneous Angiosarcoma of the Scalp: A Case Report of Sustained Complete Response Following Liposomal Doxorubicin and Radiation Therapy

Sarcoma ◽

10.1080/13577140500043948 ◽

2005 ◽

Vol 9 (1-2) ◽

pp. 29-31 ◽

Cited By ~ 10

Author(s):

Caroline L. Holloway ◽

A. Robert Turner ◽

George S. Dundas

Keyword(s):

Overall Survival ◽

Radiation Therapy ◽

Electron Beam ◽

Case Report ◽

Liposomal Doxorubicin ◽

Complete Response ◽

Genetic Profile ◽

Beam Radiation ◽

Electron Beam Radiation

Cutaneous angiosarcomas of the head and neck are aggressive cancers with a mean overall survival of 30 months. We add to the literature a case report of a 65-year-old man with a large, >10 cm, unresectable, angiosarcoma of the scalp who was treated with two cycles of liposomal doxorubicin (Caelyx®) followed by electron beam radiation therapy (30 Gy in 10 fractions over 2 weeks) who has sustained a complete response with a 4-year follow-up. The dose and fractionation of the radiation therapy in this case was palliative and was not expected to give lasting local control of this lesion. It is therefore possible that either the genetic profile of the tumour conferred radiosensitivity or that the radiation therapy induced a recall phenomenon of the liposomal doxorubicin.

Download Full-text